Misoprostol knowledge and distribution in Mexico City after the change in abortion law: a survey of pharmacy staff. Issue 1 (5th November 2019)

• Record Type: Journal Article
• Authors: Weaver, Greta; Schiavon, Raffaela; Collado, Maria Elena; Küng, Stephanie; Darney, Blair G
• Is Part Of: BMJ sexual & reproductive health. Volume 46:Issue 1(2020)
• Page Start: 46
• Page End: 50
• Publication Date: 2019-11-05
• Subjects: misoprostol -- medical abortion -- Mexico -- pharmacy; Reproductive health -- Periodicals; Sexual health -- Periodicals; Birth control -- Periodicals; Contraception -- Periodicals; 613.905
• DOI: 10.1136/bmjsrh-2019-200394
• Languages: English
• ISSNs: 2515-1991

Abstract

Abstract : Objective: First-trimester abortion is widely available in Mexico City since legalisation in 2007, but few data exist surrounding pharmacy staff knowledge and sales practices. We describe misoprostol availability, whether a prescription is required, and knowledge of the legal status of abortion and uses for misoprostol among pharmacy staff in Mexico City. Methods: Data were collected from 174 pharmacies in Mexico City. One employee at each pharmacy was asked about availability, need for prescription, indications for misoprostol, and sociodemographic information. Our primary outcome was availability of misoprostol. We used descriptive and bivariate statistics to compare knowledge and practices by type of pharmacy and staff gender. Patients and public involvement: No patients were involved in this study. Results: Of the 174 pharmacies, 65 were chain and 109 small independent. Misoprostol was available at 61% of sites. Only 49% of independent pharmacies sold misoprostol, compared with 81.5% of chain pharmacies (p<0.05). Knowledge of indications for misoprostol use was similar. The majority (80%) of respondents knew that abortion was legal in Mexico City, and 44% reported requiring a prescription for sale of misoprostol, with no significant difference between male and female staff or by pharmacy type. Conclusions: Availability, requirement of a prescription, and knowledge of indications for use of misoprostol varies among pharmacies, resulting in differential access to medical abortion. Pharmacies may be a good place to target education for pharmacy staff and women about safe and effective use of misoprostol for abortion.